Ackermans & Van Haaren NV (GB:0GYM) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Ackermans & van Haaren NV reports a strong third quarter in 2024, maintaining momentum with core participations like DEME and Delen Private Bank, and projects a net profit exceeding 400 million euros for the year. The company bolstered its portfolio with strategic investments in V.Group and Confo Therapeutics, while also increasing stakes in Nextensa and SIPEF. AvH’s financial position remains solid with a net cash position of 294.8 million euros as of September 2024.
For further insights into GB:0GYM stock, check out TipRanks’ Stock Analysis page.
